Proteostasis Therapeutics

PROTEOSTASIS THERAPEUTICS Inc | Pharmaceuticals and Research

Starting from year two of collaboration, we began the complete rebranding process of the company. Our task was to give PTI an identity that was accessible from both the scientific/medical community and the people of the CF community.

Nel secondo anno di collaborazione l’azienda ha deciso di passare attraverso un processo di rebranding completo. Il nostro compito era di dare a PTI un’identità che fosse sia orientata alla scienza/medicina sia alle persone della comunità CF..

42nd CF CONFERENCE

05-08 June 2019, Liverpool, UK